PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsAxsome Therapeutics
Axsome Therapeutics(AXSM)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
AuvelityDextromethorphan, Bupropion2022-08-182023-2040
Atrial fibrillation
,
Atrial flutter
,
Cardiac arrhythmias
,
Cough
,
Neurobehavioral manifestations
,
Sinusitis
,
Asthma
,
Common cold
,
Allergic rhinitis perennial
,
Urticaria
,
Vasomotor rhinitis
,
Whooping cough
,
Bronchitis
,
Pharyngitis
,
Laryngitis
,
Postoperative complications
,
Pain
,
Vomiting
,
Nausea
,
Anaphylaxis
,
Allergic conjunctivitis
,
Motion sickness
,
Tobacco use disorder
,
Attention deficit disorder with hyperactivity
,
Depressive disorder
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Rizatriptan
migraine disorders
,
headache
,
epilepsy
,
recurrence
Dextromethorphan
macular degeneration
,
retinal neovascularization
,
vitrectomy
,
radiation injuries
,
uveal neoplasms
,
uveal melanoma
,
capsule opacification
,
papilledema
,
macular edema
,
retinal vein occlusion
,
diabetes mellitus
,
diabetic retinopathy
,
edema
,
epiretinal membrane
,
posterior uveitis
,
uveitis
,
cataract
,
retinal diseases
,
ischemia
,
intermediate uveitis
,
pars planitis
,
dental deposits
,
visual acuity
Bupropion
tobacco use disorder
,
cigarette smoking
,
smoking cessation
,
alzheimer disease
,
dementia
,
psychomotor agitation
,
treatment-resistant depressive disorder
,
depression
,
major depressive disorder
,
depressive disorder
,
recurrence
Meloxicam
migraine disorders
Bupropion hydrochloride
healthy volunteers/patients
,
depression
,
depressive disorder
,
tobacco use disorder
,
overweight
,
body weight
,
type 2 diabetes mellitus
,
diabetes mellitus
,
obesity
,
cardiovascular diseases
Glutamic acid
recurrence
,
carcinoma
,
non-small-cell lung carcinoma
,
lung neoplasms
,
small cell lung carcinoma
,
adenocarcinoma of lung
,
bronchiolo-alveolar adenocarcinoma
Doconexent
follicular lymphoma
,
hematologic neoplasms
,
neoplasms
Reboxetine
narcolepsy
,
cataplexy
,
sleepiness
,
disorders of excessive somnolence
D-glutamate
schizophrenia
,
depression
,
major depressive disorder
,
depressive disorder
,
prostatic neoplasms
,
carcinoma
,
breast neoplasms
,
ovarian neoplasms
,
pancreatic neoplasms
,
sarcoma
,
ovarian epithelial carcinoma
,
non-small-cell lung carcinoma
Buproprion
healthy volunteers/patients
,
binge drinking
,
second primary neoplasms
,
alcoholism
,
non-small-cell lung carcinoma
,
lung neoplasms
,
mood disorders
,
hiv infections
,
substance-related disorders
,
smoking cessation
,
smoking
,
treatment-resistant depressive disorder
,
alzheimer disease
,
dementia
,
crohn disease
,
huntington disease
,
chorea
,
depressive disorder
,
major depressive disorder
,
depression
,
bipolar disorder
,
tobacco use disorder
Nicoderm
schizophrenia
,
crohn disease
,
cardiovascular diseases
,
coronary disease
,
diabetes mellitus
,
coronary artery disease
,
myocardial ischemia
,
heart diseases
,
peripheral arterial disease
,
peripheral vascular diseases
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use